Member Info for SickOfTheRatRace

There wasn't much to say on BMN, just the Lemur update. Confirmation that they have attributed no value to Lemur in their 87p valuation but it could turn out to have significant value. No surprise there.

Plus blaming the Vanadium price fall on Brexit saying the Chinese are trying to sell Vanadium into Europe but we aren't buying.

Excellent RNS. Progressing well on all fronts. Wonderful to hear that the BFS has been signed off.

Can only echo BBN's comments earlier about the right to electricity.

In terms of the immediately seized on potential delay to the estimates for Brits, no issue with this whatsoever. My frustration has always been self imposed deadlines passing with no comment from the company. In this instance although the expected announcement will be delayed they are keeping us informed of this. Although of course disappointing that the announcement will be delayed the key here is that it is communicated so we know what to expect. No problem with this at all.

I don't agree with the earlier comment that the Vametco resource isn't significant. Not only will the guidance massively increase the overall resource it will add significant value to the overall company valuation for any future sale which ultimately will benefit all shareholders.

@faramog that was 993444 I believe, now to be found commenting on ATM.

Although not invested in Debenhams I feel for any shareholder that took the word of the board in RNS releases which appear to be over optimistic at best and at worst fraudulent. I haven't followed all of the process in depth but it would appear from outside that there was a definite and clear path with Mike Ashley to protect at least some of the shareholder value and whether out of stubbornness or vindictiveness the Debenhams board ignored this and shareholders being wiped out is the result.

It is a good lesson and reminder of the risks that all investors take going "all in" on a share. Of course UK retail cannot be directly compared with a South African miner and each decision to go all in on any share is a personal decision by the investor and largely driven by their appetite for risk. In it's early pre-Vametco stages BMN was high risk with no income - the fact that we are where we are today is testament to the foresight and strategic thinking by the board and if Vametco hadn't happened we could easily have been wiped out as a result.

Personally I view being all in on BMN today as infinitely preferable to being all in during those early days. The fact is that the biggest money on AIM is made by those making those high risk early days investments and riding the upward path. If you want the biggest return you take the biggest risk and can easily be wiped out in the process as so many have been before and indeed will be in future.

Wul_1976 days like today and those in history remind us of the need to always re-evaluate our investments periodically, remind ourselves why we are invested and decide if we are still happy with the risks we take.

It is never nice to read the stories of those who literally bet their house and lost and regardless of whether that decision was a sound one or not I hope SPF gets the necessary help and support they clearly need.

I think Bed&ISA's are going to affect things for the rest of this week unfortunately.

My name is relatively self explanatory, I am sick of the 9-5 grind that mostly only funds the ridiculous material purchases of my boss that have little meaning and I hope to retire to the coast on the back of a BMN buyout at some point in the next few years.

Part of my frustration with mining is just how long everything takes and every extra day or delay is a day longer until I can realise my personal dreams and enjoy the rest of my life in relative peace. I was hoping to be semi-retired already this year with a share price around 70p by now, but clearly that isn't happening.

Linus has the comfort blanket

Alfa I believe you can only offset the loss against profits on the sale if you are out for at least 30 days, so a Bed and ISA wouldn't allow for this? Might be wrong, I am no expert on this.

https://www.fool.com/knowledge-center/can-i-sell-and-buy-shares-in-the-same-stock-within.aspx

@LinkedDreams Obviously you haven't said what x is. If you have a small number of shares outside of a tax free wrapper then it's a small amount of housekeeping, although you are realising a small loss you are immediately buying back for a similar value. Also consider how you would feel paying tax on a dividend. There is a strong possibility that some kind of dividend will be paid this year, so if you don't transfer the shares now you could also be losing out on a chunk of dividend income, depending on your current circumstances and whether you fall into the £1,000 or £500 of interest/dividend tax free bracket. That's really why the value x is important to know because if you are talking a very low number of shares then the dividend won't be enough (at least initially) to trouble your allowances.

Hi sldmr

Sorry I missed you this year! Incredible that you actually got to speak to Jamie Gibson, I don't suppose you asked him to justify his salary?

Pleased by your post as you are clearly positive going forward which is reassuring.

Absolutely bignose I think we all are. If I recall correctly USA launch was supposed to be this year and has been repeatedly pushed back. I believe some of this was because it was originally thought that EU trial data could be used to "fast track" the FDA process with minimal extra data. The chart on the wall at the show now has:

Phase II - 008 clinical study readout Q1 2020
Phase III - 008 clinical study readout Q1 2021
Estimate of FDA approval in Q1 2022 with a 2022 US launch.

For China we have End of 2019 for "Submit dossier to NMPA"
Q1 2020 for Pre-IND meeting
Q3 2020 for CTA approval
Phase 1 +III sudy (18 months) shown as 2020
Q3 2022 Pre-NDA meeting
End of 2022 NDA submission
Q3/4 2023 NDA approval
Est. 2023 launch

Just to highlight how long that process is going to be, the EU exclusivity expires in 2023.

The only mention on stand of HK etc was some key blurb points about Orient EuroPharma.

Excellent info Alfa, many thanks for this. Good to see in pictures some of the work that is going on to shrink the footprint of these devices to get them into more markets/applications. The more markets, the more Vanadium that will be needed which gives us lowly investors more security going forward.

With that last unit and the clamping structure eliminated by welding, although that reduces weight does it also increase maintenance costs? If there is a problem are the units field serviceable or are they now sufficiently small that it is easier to just swap out if there is an issue?

No problem and appreciate the thanks.

Let's hope the positivity translates into good numbers and we can get this share price up.

Unfortunately Dr Mike was unable to make it on this occasion. The stand was staffed by a gentleman I haven't seen before called Romero who said he works as part of a team of four in the UK under the Plethora name which includes Dr Mike.

Apparently the decision to have the stand at all was only taken late on and Dr Mike already had holiday booked. Strange as the date of the show is known well in advance so make of that what you will.

It was claimed that Jamie Gibson was at the show which was somewhat of a shock to hear but I certainly didn't see him at the stand in the time I was there.

There isn't a lot to say other than China is due to launch 2023 and USA 2022. However as the USA was previously going to launch this year whether we can trust those dates or not I don't know. I took a few images of the wall information posters and will read in detail this week to see if there is anything new.

I did ask Romero about sales and he seemed positive about sales numbers and Recordati. Annual report due soon.

In regards to your question about alternative uses as bignose58 already mentioned they were looking to use the absorbtion technology for burns patients. That isn't new information but something Dr Mike mentioned at a previous show in terms of alternative uses. Obviously I couldn't ask Dr Mike if there was any progress on this as he wasn't there.

By the way Pulseflow (Diabetic Boot) were next door to Plethora and had demonstration products to hand. Whether it is or was a good RP investment or not you can decide for yourself, personally I like the product and it's USP and I hope it is successful.

To be honest I didn't stay at the show that long this year. Many of the stalls were quite spartan. Anyone who has been knows it it pretty much a showcase for various Jim Mellon investments and as we know there is an increasing focus on life sciences as Jim realises he isn't getting any younger and wants to invest his millions in trying to extend his own time now he is in his 60's.

Not sure if sldmr is still invested and went to the show as usual, he may be able to add more to the above.

Thanks for part 3 Alfa, I will enjoy the read later this morning. Hopefully I will have to read an RNS first, we can but dream.

@Headancer I have been of the opinion "Strong Buy" since as long as I can remember and my posts are tagged as such.

This comes up from time to time and there are several posters already expressing their opinion in each post. Of course if you are suggesting others do it then it may be a good idea when suggesting to use the function yourself so others can see what you mean.

In terms of the opinion however it doesn't go far enough, but then I guess "Certain Buy" or "Unquestionable buy" might be a bit extreme for some, so strong buy will have to do for now!

@getbusy I believe someone here got burnt some time ago leaving it to the last minute and it didn't go through. I believe the excuse from the provider was that the requests are submitted and processed in due turn and the queue was too long to get processed in time. Something like that.

Arvin08 you suggested it is happening here. "This may explain our continuous Sp drop!"

Arvin08 there is no evidence to suggest that BMN need to perform a placing of any kind given they are making millions in profit.

@UKSteveg Did he fit the optional anti-carjacking flame throwers?